| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.18 | 8e-05 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |